MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion
by
Aguirre N, Ballaz S, Lasheras B, Del Rio J
Department of Pharmacology,
University of Navarra Medical School, Pamplona, Spain.
Eur J Pharmacol 1998 Apr 10; 346(2-3):181-8

ABSTRACT

One week after a single administration of 3,4-methylenedioxymethamphetamine (MDMA HCI, 30 mg/kg i.p.), 5-HT1A receptor density was significantly increased by approximately 25-30% in the frontal cortex and hypothalamus of rats. The increased density correlated with the potentiation of the hypothermic response to the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT, 1 mg/kg s.c.). Hypothalamic 5-HT7 receptors, which also bind 8-OH-DPAT, were not changed, however, by MDMA. Fluoxetine (5 mg/kg s.c.), ketanserin (5 mg/kg s.c.) or haloperidol (2 mg/kg i.p.), given 15 min prior to MDMA, prevented the depletion of 5-hydroxytryptamine (5-HT) induced by MDMA and also blocked the effects of this neurotoxin on 5-HT1A receptor density and on 8-OH-DPAT-induced hypothermia. The protection afforded by drugs against 5-HT loss did not correlate, however, with the antagonism of the acute hyperthermic effect of MDMA. The present results indicate that drugs able to prevent or to attenuate MDMA-induced 5-HT loss also prevent the changes in 5-HT1A receptor density as well as the enhanced hypothermic response to the 5-HT1A receptor agonist 8-OH-DPAT in MDMA-treated rats.

MDMA
SSRIs
5-HT2
5-HT1a
Serotonin
Dopamine
Fluoxetine
Entactogens
Empathogens
Serotonin Dip
MDMA and MAO
Alexander Shulgin
L-deprenyl and Ecstasy

HOME
HedWeb
HerbWeb
BLTC Research
Empathogens.com
The Good Drug Guide
Paradise-Engineering
The Hedonistic Imperative